ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756053; 2) Community: the network communities that were significantly associated with the response to NSC 756053; 3) Molecule: the relationships between components within communities and NSC 756053; 4) MDR: the compounds that were significantly associated with the NSC 756053.

NSC Compound Enrichment Correlation
NSC 709362 Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- 0.0105972823829604 -0.17251722
NSC 714636 Null 0.0105972823829604 0.19686385
NSC 716142 Null 0.0105972823829604 0.36236627
NSC 724596 S-(dimethylarsino)-3-mercapto-1,2-propanediol 0.0105972823829604 -0.00875708
NSC 726146 Null 0.0105972823829604 -0.065562194
NSC 727082 16-[3-Methoxy-4-(2-piperidin-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0105972823829604 -0.017410655
NSC 733397 1-alpha-methyl-8-methoxy-5-bromo-6,7,-methylenedioxy-1-(6,7, -dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinoline 0.0105972823829604 -0.28642986
NSC 762008 Copper(II) complex with a thiosemicarbazone as a ligand 0.0105972823829604 0.19193835
NSC 299117 24-Norchola-20,22-diene-4-carboxaldehyde, 3,12-bis(acetyloxy)-14,15:21,23-diepoxy-1,7,19-trihydroxy-4,8-dimethyl-11-oxo-, cyclic 4,19-(acetyl acetal), [1.alpha.,3.alpha.,4.beta.(S),5.alpha.,7.alpha., 0.0108954273764103 -0.15882327
NSC 305782 2,4-Quinazolinediamine, 6-[[3-(trifluoromethyl)phenyl]thio]- 0.0108954273764103 -0.30554939
Total:76  Current:19    [First] [Prev] [Next] [Last]